Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up.

导出 LinkOut

翻译打印收藏纠错

第一作者： Lucas N L,Van Aelst

第一单位： Department of Cardiovascular Sciences, Catholic University of Leuven, Leuven, Belgium.

作者： Lucas N L,Van Aelst ^[1] ; Marjorie,Abraham ^[2] ; Malha,Sadoune ^[3] ; Thibaud,Lefebvre ^[3] ; Philippe,Manivet ^[4] ; Damien,Logeart ^[5] ; Jean-Marie,Launay ^[3] ; Zoubida,Karim ^[6] ; Hervé,Puy ^[7] ; Alain,Cohen-Solal ^[2]

作者单位： Department of Cardiovascular Sciences, Catholic University of Leuven, Leuven, Belgium. ^[1] Department of Cardiology, Lariboisière Hospital, Paris, France. ^[2] U942 INSERM BIOCANVAS (Biomarqueurs Cardiovasculaires), Paris, France. ^[3] INSERM U1149, Centre de Recherche sur l'Inflammation, University of Paris VII Denis Diderot, Paris, France. ^[4] Laboratory of Excellence, GR-Ex Imagine Institute, Paris, France. ^[5] Medical Biochemistry and Molecular Biology, Lariboisière Hospital, Paris, France. ^[6] Biossip Analytical Platform, Centre for Biological Resources BB-0033-00064, Lariboisière Hospital, Paris, France. ^[7] Department of Cardiology, University of Paris VII Denis Diderot, Paris, France. ^[8]

关键词 Heart failure biomarkers ferritin hepcidin iron deficiency treatment